Gold Compounds as Anticancer Agents: Chemistry, Cellular Pharmacology, and Preclinical Studies

被引：1
|
作者：
Nobili, Stefania
Mini, Enrico
Landini, Ida
Gabbiani, Chiara
Casini, Angela
Messori, Luigi
机构：
来源：
MEDICINAL RESEARCH REVIEWS | 2010年 / 30卷 / 03期
关键词：
PROTEIN-KINASE-C; DNA-BINDING PROPERTIES; LIGAND-EXCHANGE REACTIONS; GOLD(III) PORPHYRIN 1A; THIOREDOXIN REDUCTASE; CANCER-CELLS; ORGANOGOLD(III) COMPOUNDS; ANTITUMOR-ACTIVITY; CRYSTAL-STRUCTURE; SERUM-ALBUMIN;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：550 / 580
页数：31
相关论文
共 50 条
  • [1] GOLD COMPOUNDS - THEIR CHEMISTRY PHARMACOLOGY AND PHARMACY
    NINEHAM, AW
    ARCHIVES OF INTERAMERICAN RHEUMATOLOGY, 1963, 6 (01): : 113 - +
  • [2] Gold (I) anticancer agents: Building blocks for the synthesis of bimetallic compounds, bioconjugates and nanocarrier payloads. Preclinical studies
    Contell, Maria
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [3] Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents
    Gabbiani, Chiara
    Cinellu, Maria Agostina
    Maiore, Laura
    Massai, Lara
    Scaletti, Federica
    Messori, Luigi
    INORGANICA CHIMICA ACTA, 2012, 393 : 115 - 124
  • [4] HANDBOOK OF PRECLINICAL PHARMACOLOGY FOR ANTICANCER AGENTS METHODS AND CONTROL VALUES
    SCHOLLER, J
    TIMMENS, EK
    KELLY, VN
    CANCER CHEMOTHERAPY REPORTS, 1960, (09): : 148 - 163
  • [5] Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group
    Paola Perego
    Georg Hempel
    Stig Linder
    Tracey D. Bradshaw
    Annette K. Larsen
    Godefridus J. Peters
    Roger M. Phillips
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 427 - 441
  • [6] Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group
    Perego, Paola
    Hempel, Georg
    Linder, Stig
    Bradshaw, Tracey D.
    Larsen, Annette K.
    Peters, Godefridus J.
    Phillips, Roger M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (03) : 427 - 441
  • [7] Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents
    Wang, H
    Li, M
    Rhie, JK
    Hockenbery, DM
    Covey, JM
    Zhang, RW
    Hill, DL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (03) : 291 - 298
  • [8] Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents
    Hui Wang
    Mao Li
    Julie K. Rhie
    David M. Hockenbery
    Joseph M. Covey
    Ruiwen Zhang
    Donald L. Hill
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 291 - 298
  • [9] SOLASODINE GLYCOSIDES AS ANTICANCER AGENTS - PRECLINICAL AND CLINICAL-STUDIES
    CHAM, BE
    ASIA PACIFIC JOURNAL OF PHARMACOLOGY, 1994, 9 (02): : 113 - 118
  • [10] PRECLINICAL STUDIES FOR CHARACTERISATION OF NEW ANTICANCER AGENTS IN ANIMAL EXPERIMENTS
    BROCK, N
    ACTA UNIO INTERNATIONALIS CONTRA CANCRUM, 1964, 20 (1-2) : 45 - &
12345